Applied DNA Sciences (APDN) Misses Q3 EPS by 3c
Tweet
Share
E-mailGet Alerts APDN Hot Sheet
Price: $5.00 +1,983.33%
EPS Growth %: -540.0%
Financial Fact:
Selling, general and administrative: 1.86M
Today's EPS Names:
FRSB, DGICA, UXIN, More
EPS Growth %: -540.0%
Financial Fact:
Selling, general and administrative: 1.86M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Applied DNA Sciences (NASDAQ: APDN) reported Q3 EPS of ($0.14), $0.03 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $653 thousand versus the consensus estimate of $1.47 million.
For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- ResMed (RMD) Tops Q3 EPS by 20c
- Seacoast Banking Corporation of Florida (SBCF) Tops Q1 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
